Trump Administration Implements Six-Month Moratorium on New Medicare Hospice and Home Health Enrollments to Combat Systemic Fraud

Washington – The Trump administration announced a significant policy shift on Wednesday, May 13, 2026, enacting a six-month moratorium on new Medicare enrollments for hospice and home health agencies. This decisive action, spearheaded by the Centers for Medicare and Medicaid Services (CMS), is a direct response to what officials describe as systemic and deeply troubling fraud that has plagued these vital healthcare sectors, draining taxpayer dollars and exploiting some of the nation’s most vulnerable patients. The measure aims to stem the tide of fraudulent actors entering the Medicare program while simultaneously intensifying efforts to identify and remove existing illicit operations.

Understanding the Policy Shift and Its Rationale

The moratorium, effective immediately, targets the inflow of new providers suspected of fraudulent intent. During this six-month pause, CMS has committed to a multi-pronged approach: intensifying targeted investigations, deploying advanced data analytics to detect anomalies, and accelerating the process of removing hospice and home health agency (HHA) providers already enrolled in Medicare who are found to be committing fraud. CMS has explicitly stated that the pause will not affect current enrollments, ensuring that existing providers can continue to serve Medicare beneficiaries without interruption. This distinction is crucial, designed to minimize disruption to legitimate patient care while addressing the root causes of the fraud.

CMS Administrator Dr. Mehmet Oz articulated the administration’s resolve in a statement: "We’ve seen systemic and deeply troubling fraud in the hospice and home health space, with bad actors exploiting some of our most vulnerable Medicare patients and stealing money from the American taxpayer. Today we’re shutting the door on fraud—preventing new bad actors from entering Medicare while we aggressively identify, investigate, and remove those already exploiting them. This is about protecting patients, restoring integrity, and safeguarding taxpayer dollars." His strong language underscores the urgency and severity with which the administration views the problem.

The Broader Landscape of Hospice and Home Health Care

Hospice and home health services are critical components of the U.S. healthcare system, providing essential care for individuals nearing the end of life or recovering from illness and injury in the comfort of their homes. Hospice care focuses on palliative care for terminally ill patients, emphasizing comfort and quality of life rather than curative treatment. Home health agencies deliver skilled nursing care, physical therapy, occupational therapy, and other medical services to patients in their residences. Both sectors rely heavily on Medicare reimbursement, making them attractive targets for fraudulent schemes due to the often-complex billing structures, the vulnerability of the patient population, and the nature of care delivery, which can sometimes be less directly supervised than institutional settings.

The growth of these sectors has been substantial. As the U.S. population ages, demand for in-home and end-of-life care has surged. This expansion, while beneficial for patients, has also created opportunities for unscrupulous individuals and organizations to exploit the system. The sheer volume of claims and the specialized nature of these services can make it challenging for oversight bodies to detect fraudulent activities quickly and efficiently without sophisticated tools and focused enforcement.

A Chronology of Mounting Concerns and Investigations

The administration’s announcement is not an isolated event but rather the culmination of growing concerns and intensified scrutiny, particularly following a series of investigative reports.

2023: OIG Report Highlights Significant Fraud: The U.S. Department of Health and Human Services Office of the Inspector General (HHS OIG) reported in 2023 that suspected hospice fraud amounted to an estimated $198.1 million nationwide. This figure served as a stark indicator of the financial drain on the Medicare system, representing just a fraction of the broader healthcare fraud problem that costs taxpayers billions annually. The OIG’s ongoing work consistently identifies vulnerabilities and recommends measures to protect federal healthcare programs.

Early 2026: CBS News Investigation Uncovers Widespread Issues: A comprehensive CBS News investigation, drawing on state and federal data, brought to light alarming patterns of potentially fraudulent hospice companies and charges. The investigation highlighted California as a particular hotspot, noting an outsized number of companies offering hospice services within the state. Most notably, the report revealed that over 700 of the approximately 1,800 hospices in Los Angeles County alone triggered multiple "red flags" for fraud, as defined by state regulations. These red flags often include unusually high numbers of patients, rapid growth without corresponding infrastructure, dubious patient diagnoses, or billing for services not rendered. The sheer scale of these indicators in a single county underscored the pervasive nature of the problem.

March 2026: Administrator Oz’s Initial Pledge: In direct response to the CBS News reports, Dr. Mehmet Oz, in his capacity as CMS Administrator, announced an initiative in March to decertify any hospice providers found to be defrauding taxpayers. His focus then was on specific schemes such as stealing the identities of individuals not in hospice care or overbilling for services provided to those who are genuinely dying. This earlier pledge laid the groundwork for the broader, more aggressive action taken in May.

May 13, 2026: The Moratorium Announcement: The formal announcement of the six-month moratorium by the Trump administration on Wednesday, May 13, 2026, marks an escalation of these anti-fraud efforts, moving from targeted decertification to a preventative freeze on new entrants. This proactive measure aims to "shut the door" on new fraudulent entities before they can establish themselves within the Medicare system.

May 14, 2026: Vice President Vance’s Address: The timing of the moratorium announcement also strategically precedes a public address by Vice President JD Vance. Vance, who heads the White House’s anti-fraud task force, is scheduled to speak in Bangor, Maine, the day after the announcement, where he will elaborate on the administration’s broader efforts to combat fraud across federal programs. Vance and Oz are also slated to hold a joint press conference on Wednesday, further emphasizing the unified front of the administration against healthcare fraud.

The White House Anti-Fraud Task Force and State Accountability

The White House’s anti-fraud task force, under Vice President Vance’s leadership, plays a pivotal role in this broader campaign. The task force’s mandate extends beyond Medicare to encompass fraud across all federal programs, including Medicaid, which provides healthcare coverage to low-income individuals. In a social media post on Wednesday announcing the enrollment freeze, the task force explicitly called upon states to intensify their own efforts in combating fraud. "States aren’t entitled to taxpayer money for fraudulent Medicaid services," the task force stated. "Americans shouldn’t have to pay fraudsters and states to waste your hard-earned money. This administration and the Fraud Task Force are fighting for accountability." This statement highlights a key aspect of healthcare fraud: its intersection with state-administered programs like Medicaid, where federal funds are often matched by state contributions, making state-level enforcement crucial. The task force’s message underscores a push for shared responsibility and accountability across all levels of government.

Mechanisms of Enforcement and Fraud Detection

During the moratorium, CMS will leverage several mechanisms to achieve its objectives:

• Intensified Targeted Investigations: This involves deploying dedicated teams to investigate providers identified through intelligence, complaints, or data anomalies. These investigations can include site visits, interviews, and audits of patient records and billing practices.
• Advanced Data Analytics: CMS will utilize sophisticated algorithms and machine learning to analyze vast datasets of Medicare claims. These tools can identify patterns indicative of fraud, such as unusual billing frequencies, high rates of certain diagnoses, or geographic concentrations of suspicious activity that might not be apparent through traditional methods. This proactive data mining is critical for identifying "red flags" and prioritizing investigations.
• Accelerated Removal of Fraudulent Providers: For providers found to be engaged in fraud, CMS will expedite the process of de-enrolling them from the Medicare program. This includes revoking billing privileges and, where appropriate, referring cases for criminal prosecution. The goal is to swiftly sever the financial lifeline for illicit operations.

These actions align with established anti-fraud strategies that combine prevention (the moratorium), detection (data analytics), and enforcement (investigations and removals).

Broader Implications and Stakeholder Reactions

The moratorium is expected to have several implications across the healthcare landscape:

• Impact on Legitimate Providers: While existing providers are not directly affected, the heightened scrutiny and intensified investigations could lead to increased administrative burdens for all hospice and home health agencies as CMS enhances its oversight. Legitimate providers, while supportive of efforts to eliminate fraud, may express concerns about potential delays in processing legitimate applications once the moratorium lifts, or about being caught in the wider net of investigations. Industry associations are likely to issue statements supporting fraud prevention while also advocating for their ethical members.
• Patient Access to Care: CMS has assured that current beneficiaries will not be impacted. However, in areas with high demand and limited existing providers, a six-month freeze on new enrollments could, in theory, impact future access if demand outstrips the capacity of legitimate existing providers to expand. This will be a critical area for CMS to monitor. Patient advocacy groups are likely to welcome the focus on protecting vulnerable populations from exploitation, while also urging CMS to ensure that anti-fraud measures do not inadvertently create barriers to essential care.
• Financial Savings: If successful, the moratorium and intensified enforcement could lead to substantial savings for the Medicare program, redirecting taxpayer dollars away from fraudulent schemes and towards legitimate patient care. This aligns with the administration’s stated goal of safeguarding taxpayer funds.
• Reputational Impact: The moratorium sends a strong signal about the administration’s commitment to tackling healthcare fraud, potentially enhancing its reputation for fiscal responsibility and patient protection. For the hospice and home health industries, successful fraud eradication could restore public trust and enhance their overall standing.
• Future Policy Directions: This aggressive action could pave the way for more stringent, permanent changes to Medicare enrollment processes, including more thorough background checks, enhanced financial solvency requirements, and continuous monitoring of providers. It might also lead to greater collaboration between federal and state authorities in combating healthcare fraud across both Medicare and Medicaid programs. Legal and compliance experts will be watching to see if this moratorium sets a precedent for similar actions in other high-risk healthcare sectors.

Conclusion

The Trump administration’s six-month moratorium on new Medicare enrollments for hospice and home health agencies represents a significant escalation in its fight against healthcare fraud. Driven by compelling evidence from federal reports and journalistic investigations, particularly in areas like Los Angeles County, the policy aims to protect vulnerable patients and safeguard taxpayer dollars from systemic exploitation. By combining a preventative freeze on new entrants with intensified investigations and data-driven enforcement against existing fraudulent actors, CMS and the White House Anti-Fraud Task Force are signaling a robust commitment to restoring integrity to these critical healthcare services. The coming months will be crucial in demonstrating the effectiveness of these measures and their broader impact on the future landscape of hospice and home health care in the United States.